Search Results - "PATCH, D."

Diffusion and partitioning of different PFAS compounds through thermoplastic polyurethane and three different PVC-EIA liners by Rowe, R.K., Barakat, F.B., Patch, D., Weber, K.

“…Perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorobutane sulfonic acid (PFBS), 6:2 fluorotelomer sulfonic acid (6:2 FTS), and GenX are…”
Get full text

PFOA and PFOS diffusion through LLDPE and LLDPE coextruded with EVOH at 22 °C, 35 °C, and 50 °C by Di Battista, V., Rowe, R. Kerry, Patch, D., Weber, K.

“…•First diffusion study of per- and polyfluoroalkyl substances through geomembranes.•Provides parameters for calculating the impact of PFAS in MSW leachate to…”
Get full text

Systematic review: the model for end‐stage liver disease – should it replace Child‐Pugh's classification for assessing prognosis in cirrhosis? by CHOLONGITAS, E., PAPATHEODORIDIS, G. V., VANGELI, M., TERRENI, N., PATCH, D., BURROUGHS, A. K.

“…Summary Background:  Prognosis in cirrhotic patients has had a resurgence of interest because of liver transplantation and new therapies for complications of…”
Get full text

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma by Meyer, T, Kirkwood, A, Roughton, M, Beare, S, Tsochatzis, E, Yu, D, Davies, N, Williams, E, Pereira, S P, Hochhauser, D, Mayer, A, Gillmore, R, O'Beirne, J, Patch, D, Burroughs, A K

“…Background: Transarterial chemoembolisation (TACE) has not been shown to be superior to bland embolisation (TAE) for treatment of hepatocellular carcinoma…”
Get full text

Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC by Stigliano, R, Marelli, L, Yu, D, Davies, N, Patch, D, Burroughs, A K

“…Tumour biopsy is usually considered mandatory for patient management by oncologists. Currently percutaneous ablation is used therapeutically for cirrhotic…”
Get full text

Risk factors, Sequential Organ Failure Assessment and Model for End‐stage Liver Disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit by CHOLONGITAS, E., SENZOLO, M., PATCH, D., KWONG, K., NIKOLOPOULOU, V., LEANDRO, G., SHAW, S., BURROUGHS, A. K.

“…Summary Background  Prognostic scores in an intensive care unit (ICU) evaluate outcomes, but derive from cohorts containing few cirrhotic patients. Aims  To…”
Get full text

Nutritional status and prognosis in cirrhotic patients by GUNSAR, F., RAIMONDO, M. L., JONES, S., TERRENI, N., WONG, C., PATCH, D., SABIN, C., BURROUGHS, A. K.

“…SUMMARY Background and Aim  The potential prognostic value for survival of nutritional status in cirrhotics after adjusting Child–Pugh classification and Model…”
Get full text

Review article: renal function assessment in cirrhosis – difficulties and alternative measurements by CHOLONGITAS, E., SHUSANG, V., MARELLI, L., NAIR, D., THOMAS, M., PATCH, D., BURNS, A., SWENY, P., BURROUGHS, A. K.

“…Summary Background  Renal function in patients with cirrhosis is important prognostically, both before and following liver transplantation. Its prognostic…”
Get full text

Infection, coagulation, and variceal bleeding in cirrhosis by Thalheimer, U, Triantos, C K, Samonakis, D N, Patch, D, Burroughs, A K

“…A particularly important role is played by the reduced RES activity, due to the presence of extrahepatic and intrahepatic shunts through sinusoids without…”
Get full text

Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club by Wong, F, Bernardi, M, Balk, R, Christman, B, Moreau, R, Garcia-Tsao, G, Patch, D, Soriano, G, Hoefs, J, Navasa, M

“…Sepsis is a systemic inflammatory response to the presence of infection, mediated via the production of many cytokines, including tumour necrosis factor…”
Get full text

When banding fails; investigation hails by Arnold, F, Patch, D, Yu, D, Westbrook, R H

Get more information

Nine scoring models for short‐term mortality in alcoholic hepatitis: cross‐validation in a biopsy‐proven cohort by Papastergiou, V., Tsochatzis, E. A., Pieri, G., Thalassinos, E., Dhar, A., Bruno, S., Karatapanis, S., Luong, T. V., O'Beirne, J., Patch, D., Thorburn, D., Burroughs, A. K.

“…Summary Background Several prognostic models have emerged in alcoholic hepatitis (AH), but lack of external validation precludes their universal use. Aim To…”
Get full text

Tips for portal vein thrombosis (pvt) in cirrhosis: Not only unblocking a pipe by Senzolo, Marco, Burra, Patrizia, Patch, D, Burroughs, Andrew K

Get full text

Porto- systemic shunt embolization and recurrent ascites:a single centre case series by Privtera, G, Figorilli, F, Mehta, G, MacNaughtan, J, Patch, D, Yu, D, Jalan, R

Get full text

Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics by CHOLONGITAS, E., SENZOLO, M., PATCH, D., SHAW, S., HUI, C., BURROUGHS, A. K.

“…Summary Background Cirrhotic patients admitted to intensive care units (ICU) still have poor outcomes. Some current ICU prognostic models [Acute Physiology and…”
Get full text

Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies by Xirouchakis, E., Triantos, C., Manousou, P., Sigalas, A., Calvaruso, V., Corbani, A., Leandro, G., Patch, D., Burroughs, A.

“…Pegylated interferon with ribavirin (Peg/R) is the most effective therapy for chronic hepatitis C virus (HCV) but its utility and effectiveness after liver…”
Get full text

Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation by SENZOLO, M., TIBBALS, J., CHOLONGITAS, E., TRIANTOS, C. K., BURROUGHS, A. K., PATCH, D.

“…Summary Background Treatment options for patients with portal vein thrombosis are limited. Aim To evaluate the feasibility and efficacy of transjugular…”
Get full text

The Royal Free Hospital ‘hub-and-spoke network model’ delivers effective care and increased access to liver transplantation by Tai, D., Dhar, A., Yusuf, A., Marshall, A., O'Beirne, J., Patch, D., Tsochatzis, E., Alexander, G., Portal, J., Thalheimer, U., Thorburn, D., Kallis, Y., Westbrook, R.H.

“…‘Hub-and-spoke’ networks may be one solution to reduce the geographical inequality in access to liver transplantation (LT) and the growing demands on, and…”
Get full text

Female Liver Transplant Recipients with the Same GFR as Male Recipients Have Lower MELD Scores—A Systematic Bias by Cholongitas, E., Marelli, L., Kerry, A., Goodier, D. W., Nair, D., Thomas, M., Patch, D., Burroughs, A. K.

“…Women have lower glomerular filtration (GFR) than men for the same serum creatinine (Cr) value, not accounted for in model for end‐stage liver disease (MELD)…”
Get full text

Non-Selective Beta Blockers (NSBBS) Use is Associated with Improved Survival in Cirrhotic Patients with Ascites: A Single Centre Retrospective Study by Onali, S, Kalafateli, M, Majumdar, A, Westbrook, R, O’Beirne, J, Patch, D, Tsochatzis, E

Get full text